Stockchase Opinions

Jim Cramer - Mad Money NantKwest NK-Q RISKY Feb 26, 2021

A terrific immunotherapy company and a business that he really likes. All it takes is selling one good drug to another major company, but this is a spec play.
$32.510

Stock price when the opinion was issued

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.